← All stocks

Lexeo Therapeutics, Inc.

LXEO Net buying
CIK 0001907108 #3249 in the set updated 17 Sep 2026
Bought (120 mo)
$12.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.34M
$791.55K on a plan · $790.79K straight out of an exercise
Sold at will
$757.55K
39 of 52 sales
Net
+$10.26M
+$11.85M against sales at will

By person

13 insiders · 56 transactions
2.9×

R. Nolan Townsend holds only 2.9 times base salary in stock. $1.86M of shares against $632.70K in salary for 2025.

Salary from the company's own proxy. The shares are what R. Nolan Townsend last reported holding, valued at $4.96, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Longitude Capital Partners IV, LLC entity
10% owner
$5.00M (1)
+$5.00M
2,567,100
$12.73M
Omega Fund VI, L.P. entity
10% owner
$5.00M (1)
+$5.00M
2,157,623
$10.70M
Lundbeckfond Invest A/S
10% owner
$2.50M (1)
+$2.50M
1,835,959
$9.10M
Townsend Richard Nolan
Chief Executive Officer
$1.96M (23) scheduled
−$1.96M
374,472
$1.86M
+191.3%
CHOLMONDELEY PAULA H
Director
$104.85K (1)
+$104.85K
30,627
$151.82K
+96.0%
Bhalla Narinder Pal
Chief Medical Officer
$98.59K (1)
−$98.59K
82,194
$407.44K
Otero Jose Manuel
Chief Operating Officer
$92.16K (8)
−$92.16K
136,178
$675.05K
Adler Eric
Chief Medical Officer
$50.81K (6)
−$50.81K
72,646
$360.11K
Robertson Jenny
Chief Legal Officer
$49.87K (6)
−$49.87K
68,381
$338.97K
See Tai Sandi
Chief Development Officer
$47.70K (6)
−$47.70K
65,476
$324.57K
+293.8%
Tamayo Louis Edward
Chief Financial Officer
$41.04K (2)
−$41.04K
92,907
$460.55K
Rasbach Kyle
Chief Financial Officer
40,875
$202.62K
McCormac Paul
Chief Technical Officer
17,349
$86.00K
+22.5%

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 33,065,947 to 82,046,255 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
CHOLMONDELEY PAULA H
25 Nov 2024
Director
Buy
15,000
$6.99
$104.85K
Longitude Capital Partners IV, LLC
7 Nov 2023
10% owner
Buy indirect
454,545
$11.00
$5.00M
Lundbeckfond Invest A/S
7 Nov 2023
10% owner
Buy
227,272
$11.00
$2.50M
Omega Fund VI, L.P.
7 Nov 2023
10% owner
Buy
454,545
$11.00
$5.00M

What was left out

Form 4 filings counted 94
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 10
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 6,488,985
History held since 9 Nov 2023